Global Chinese Medicine Formula Granules Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033
Delivery：Within 72h| Full Report Selling Price |
|---|
2800.00 USD |
4200.00 USD |
5600.00 USD |
| Buy NowContact Us |
| Competitor Data Selling Price |
|---|
900.00 USD |
1350.00 USD |
1800.00 USD |
| Buy NowContact Us |
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Chinese Medicine Formula Granules market size will reach 1,932.28 Million USD in 2026 and is projected to reach 4,039.63 Million USD by 2033, with a CAGR of 11.11% (2026-2033). Notably, the China Chinese Medicine Formula Granules market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Chinese medicine formula granules are a modern form of traditional Chinese herbal medicine that has been processed into granular form for convenient consumption. These granules are made by extracting active ingredients from various medicinal herbs, roots, and other natural substances, then drying and pulverizing them into small particles. The resulting granules can be easily dissolved in water to create herbal decoctions, which are traditional medicinal drinks used in Chinese herbal therapy. Chinese medicine formula granules offer several advantages over traditional raw herbs, including ease of storage, precise dosing, and quicker preparation time. They are commonly used by practitioners of traditional Chinese medicine (TCM) and are increasingly popular among patients seeking natural remedies for various health conditions. The granules retain the therapeutic properties of the original herbs and are often prescribed in customized formulations tailored to individual patient needs.
The major global manufacturers of Chinese Medicine Formula Granules include Hubei Chenmei Traditional Chinese Medicine Co., Ltd., Jiangsu Kangyuan Pharmaceutical Co., Ltd., Hunan Xinhui Pharmaceutical Co., Ltd., Zhejiang Jingyuetang Pharmaceutical Co., Ltd., Sinopharm Tongjitang (Guizhou) Pharmaceutical Co., Ltd., Sichuan New Green Pharmaceutical Technology Development Co., Ltd., Shijiazhuang Yiling Pharmaceutical Co., Ltd., Henan Hongri Kangrentang Pharmaceutical Co., Ltd., Hubei Yizheng Pharmaceutical Co., Ltd., Tiandi Hengyi Pharmaceutical., Liaoning SPH Good Nursing Pharmaceutical ((Group) Co., Ltd., Shineway Pharmaceutical Group Co., Ltd., China Resources Sanjiu Modern Chinese Medicine Pharmaceutical Co., Ltd., Beijing Chunfeng-Fang Pharmaceutical Co., Ltd., Inner Mongolia Kangpu Pharmaceutical, Guangdong Yifang Pharmaceutical Co., Ltd., Anhui Jiuzhou Fangyuan Pharmaceutical Co., Ltd., Beijing Kangrentang Pharmaceutical Co., Ltd., Jiangyin Tianjiang Pharmaceutical Co., Ltd., etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Chinese Medicine Formula Granules. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Chinese Medicine Formula Granules market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Chinese Medicine Formula Granules market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Chinese Medicine Formula Granules industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Chinese Medicine Formula Granules Include:
Hubei Chenmei Traditional Chinese Medicine Co., Ltd.
Jiangsu Kangyuan Pharmaceutical Co., Ltd.
Hunan Xinhui Pharmaceutical Co., Ltd.
Zhejiang Jingyuetang Pharmaceutical Co., Ltd.
Sinopharm Tongjitang (Guizhou) Pharmaceutical Co., Ltd.
Sichuan New Green Pharmaceutical Technology Development Co., Ltd.
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Henan Hongri Kangrentang Pharmaceutical Co., Ltd.
Hubei Yizheng Pharmaceutical Co., Ltd.
Tiandi Hengyi Pharmaceutical.
Liaoning SPH Good Nursing Pharmaceutical ((Group) Co., Ltd.
Shineway Pharmaceutical Group Co., Ltd.
China Resources Sanjiu Modern Chinese Medicine Pharmaceutical Co., Ltd.
Beijing Chunfeng-Fang Pharmaceutical Co., Ltd.
Inner Mongolia Kangpu Pharmaceutical
Guangdong Yifang Pharmaceutical Co., Ltd.
Anhui Jiuzhou Fangyuan Pharmaceutical Co., Ltd.
Beijing Kangrentang Pharmaceutical Co., Ltd.
Jiangyin Tianjiang Pharmaceutical Co., Ltd.
Chinese Medicine Formula Granules Product Segment Include:
Cold Medication
Pain Medication
Others
Chinese Medicine Formula Granules Product Application Include:
Medical Institutions
Retail Pharmacy
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Chinese Medicine Formula Granules Industry PESTEL Analysis
Chapter 3: Global Chinese Medicine Formula Granules Industry Porter's Five Forces Analysis
Chapter 4: Global Chinese Medicine Formula Granules Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Chinese Medicine Formula Granules Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Chinese Medicine Formula Granules Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Chinese Medicine Formula Granules Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Global Chinese Medicine Formula Granules Revenue, Sales and Market Share by Player
| Revenue (US$ Million) | 2020 | 2021 | 2022 | 2023 | 2024 |
| Hubei Chenmei Traditional Chinese Medicine Co., Ltd. | XX | XX | XX | XX | XX |
| Jiangsu Kangyuan Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Hunan Xinhui Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Zhejiang Jingyuetang Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Sinopharm Tongjitang (Guizhou) Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Sichuan New Green Pharmaceutical Technology Development Co., Ltd. | XX | XX | XX | XX | XX |
| Shijiazhuang Yiling Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Henan Hongri Kangrentang Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Hubei Yizheng Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Tiandi Hengyi Pharmaceutical. | XX | XX | XX | XX | XX |
| Liaoning SPH Good Nursing Pharmaceutical ((Group) Co., Ltd. | XX | XX | XX | XX | XX |
| Shineway Pharmaceutical Group Co., Ltd. | XX | XX | XX | XX | XX |
| China Resources Sanjiu Modern Chinese Medicine Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Beijing Chunfeng-Fang Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Inner Mongolia Kangpu Pharmaceutical | XX | XX | XX | XX | XX |
| Guangdong Yifang Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Anhui Jiuzhou Fangyuan Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Beijing Kangrentang Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Jiangyin Tianjiang Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Other Companies | XX | XX | XX | XX | XX |
| Total | XX | XX | XX | XX | XX |
| Sales (K Unit) | 2020 | 2021 | 2022 | 2023 | 2024 |
| Hubei Chenmei Traditional Chinese Medicine Co., Ltd. | XX | XX | XX | XX | XX |
| Jiangsu Kangyuan Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Hunan Xinhui Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Zhejiang Jingyuetang Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Sinopharm Tongjitang (Guizhou) Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Sichuan New Green Pharmaceutical Technology Development Co., Ltd. | XX | XX | XX | XX | XX |
| Shijiazhuang Yiling Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Henan Hongri Kangrentang Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Hubei Yizheng Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Tiandi Hengyi Pharmaceutical. | XX | XX | XX | XX | XX |
| Liaoning SPH Good Nursing Pharmaceutical ((Group) Co., Ltd. | XX | XX | XX | XX | XX |
| Shineway Pharmaceutical Group Co., Ltd. | XX | XX | XX | XX | XX |
| China Resources Sanjiu Modern Chinese Medicine Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Beijing Chunfeng-Fang Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Inner Mongolia Kangpu Pharmaceutical | XX | XX | XX | XX | XX |
| Guangdong Yifang Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Anhui Jiuzhou Fangyuan Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Beijing Kangrentang Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Jiangyin Tianjiang Pharmaceutical Co., Ltd. | XX | XX | XX | XX | XX |
| Other Companies | XX | XX | XX | XX | XX |
| Total | XX | XX | XX | XX | XX |
Related Report
Global Dydrogesterone Drug Competitive Landscape Professional Research Report 2026
Global Dydrogesterone Drug Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033
Global Olanzapine Competitive Landscape Professional Research Report 2026
Global Olanzapine Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033
Global Oligonucleotide Pool Library Competitive Landscape Professional Research Report 2026
Global Oligonucleotide Pool Library Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033
Global Oligonucleotide Therapeutics Competitive Landscape Professional Research Report 2026
Global Oligonucleotide Therapeutics Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033
Order Process
Contact
1. Fill in your contact information, and the company will quickly match the specialist to get in touch with you
2. You can also directly call our customer service hotline or add customer service WeChat
Samples
1. One on one business specialist will send the complete version of the sample
2. If you need to customize the report, professional analysts will be arranged to communicate with you one-on-one and provide you with customized samples
Payment
1. Both parties sign a report purchase contract
2. Support Paypal, Visa, UnionPay and MasterCard Payment
Delivery
1. PDF report (sent online 2-3 working days after payment)
2. WORD version report (sent online 2-3 working days after payment)
3. Paper version report (sent via EMS or DHL within 3-5 working days after payment)
After-Sales
Within six months of purchasing the report, if you have any questions about the details of our report, you can contact the report analyst at any time. The analyst will continue to follow up and solve your problem until you are satisfied
